Cargando…
B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover
The therapeutic efficacy of B-cell depletion by anti-CD20 treatment in pediatric and, more recently, in adult idiopathic nephrotic syndrome patients suggests a key role of B cells in the pathogenesis of the disease. However, their exact role is still unclear. B cells are able to secrete a large vari...
Autores principales: | Colucci, Manuela, Oniszczuk, Julie, Vivarelli, Marina, Audard, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819007/ https://www.ncbi.nlm.nih.gov/pubmed/35140723 http://dx.doi.org/10.3389/fimmu.2022.823204 |
Ejemplares similares
-
Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016) -
Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015) -
Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018) -
Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020) -
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)